In Vitro Anti-Inflammatory Effects of the Essential Oil of Artemisia iwayomogi and Its Main Component, Vulgarone B

  • Published : 2009.12.31

Abstract

The essential oil fraction was obtained from the leaves and flowers of Artemisia iwayomogi (Compositae) by steam distillation, and its main component, vulgarone B, was isolated by column chromatography. RAW 264.7 cells were used to investigate the anti-inflammatory properties of A. iwayomogi and vulgarone B. Cell viability was determined by MTT assay after treatment with various dilutions of the compounds. In addition, several assays were used to determine the effects of A. iwayomogi essential oil components on immune stimulation. Nitric oxide production in cells activated with lipopolysaccharide (LPS) was evaluated by reaction with Griess reagent. Both vulgarone B and the essential oil fraction of A. iwayomogi inhibited the production of nitric oxide. The effects on various cytokines released from the cells were also measured using ELISA. The production of prostaglandin $E_2$ was significantly decreased by treatment with A. iwayomogi oils. LPS-induced IL-$1{\beta}$ and IL-6 production were also decreased in a dose-dependent manner, but no significant effect on TNF-${\alpha}$ was observed at the concentrations tested. Finally, Western blot analysis revealed that A. iwayomogi oils reduced the levels of COX-2 and iNOS.

Keywords

References

  1. Ahn, B.-Y., Jung, M.Y., and Choi, D.-S., Protective activities of fractions of water extract obtained from Artemisia iwayomogi Kitamura against oxidative stress-induced mutagenesity: Correlation with their reactive oxygen scavenging activity. Food Sci. Biotech. 18, 849-854 (2009)
  2. Ahn, H., Kim, J.Y., Lee, J.Y., Kim, Y.-K., and Ryu, J.-H., Inhibitors of inducible nitric oxide synthase expression from Artemisia iwayomogi. Arch. Pharm. Res. 26, 301-305 (2003) https://doi.org/10.1007/BF02976959
  3. Kim, S.-H., Choi, C.-H., Kim, S.Y., Eun, J.-S., and Shin, T.-Y., Antiallergic effects of Artemisia iwayomogi on mast cell-mediated allergy model. Exp. Biol. Med. 230, 82-88 (2005) https://doi.org/10.1177/153537020523000111
  4. Lee, J.-A., Sung, H.-N., Jeon, C.-H., Gill, B.-C., Oh, G.-S., Youn, H.-J., and Park, J.-H., A carbohydrate fraction, AIP1 from Artemisia iwayomogi suppresses pulmonary eosinophilia and Th2-type cytokine production in an ovalbumin-induced allergic asthma. Down-regulation of TNF- expression in the lung. Int. Immunopharmacol. 8, 117-125 (2008) https://doi.org/10.1016/j.intimp.2007.10.022
  5. Meepagala, K., Kuhajek, J., Sturz, G.D., and Wedge, D.E., Vulgarone B, The antifungal constituent in the steam-distilled fraction of Artemisia douglastiana. J. Chem. Ecol. 29 1771-1780 (2003) https://doi.org/10.1023/A:1024842009802
  6. Meepagala, K, Sturz, G., Mischke, C.C., Wise, D., and Duke, S.O., Molluscidal activity of vulgarone B against ram's horn snail (Planorbella trivolvis). Pest Manag. Sci. 60, 479-482 (2004) https://doi.org/10.1002/ps.833
  7. Park, E.J., Nan, J.X., Kim, J.Y., Kang, H.C., Choi, J.H., Lee, S.J., Lee, B.H., Kim, S.J., Lee, J.H., Kim, Y.C., and Sohn, D.H., The ethanolsoluble part of a hot-water extract from Artemisia iwayomogi inhibits liver fibrosis induced by carbon tetrachloride in rats. J. Pharm. Pharmacol. 52, 875-881 (2000) https://doi.org/10.1211/0022357001774561
  8. Ryu, J.-H., Ahn, H., Kim, J.Y., and Kim, Y.-K., Inhibitory activity of plant extracts on nitric oxide synthesis in LPS-activated macrophages. Phytother. Res. 17, 485-489 (2003) https://doi.org/10.1002/ptr.1180
  9. Shin, T.-Y., Park, J.-S., and Kim, S.-H., Artemisia iwayomogi inhibits immediate-type allergic reaction and inflammatory cytokine secretion. Immunopharmacol. Immunotoxicol. 28, 421-430 (2006) https://doi.org/10.1080/08923970600927975
  10. Tewtrakul, S., Wattanapiromsakul, C., and Mahabusarakam, W., Effects of compounds from Garcinia mangostana on inflammatory mediators in RAW264.7 macrophage cells. J. Ethnopharmacol. 121, 379-382 (2009) https://doi.org/10.1016/j.jep.2008.11.007
  11. Uchio, Y., Isolation and structural determination of vulgarone A and B. Two nobel sesquiterpene ketone from Chrysanthmum vulgare. Tetrahedron 14, 2891-2899 (1978)
  12. Won, J.H., Im, H.-T., Kim, Y.-H., Yun, K.I., Park, H.-J., Choi, J.W., and Lee, K.-T., Anti-inflammatory effect of buddlejasaponin IV through the inhibition of iNOS and COX-2 expression in RAW264.7 macrophages via the NF$\hat{e}$B inactivation. Br. J. Pharmacol. 148, 216-225 (2006) https://doi.org/10.1038/sj.bjp.0706718
  13. Yu, H.-H., Kim, Y.-H., Kil, B.-S., Kim, K.-J., Jeong, S.-I., and You, Y.-O., Chemical composition and antibacterial activity of essential oil of Artemisia iwayomogi. Planta Med. 69, 1159-1162 (2003) https://doi.org/10.1055/s-2003-818011
  14. Yun, H,-J., Heo, S.-K., Yi, H.-S., Kim, C.-H., Kim, B.-W., and Park, S.-D., Anti-inflammatory effect of Injinho-tang In RAW 264.7 cells. Kor. J. Herbology 23, 169-178 (2008)
  15. Zhao, F., Wang, L., and Liu, K,. In vitro anti-inflammatory effects of arctigenin, a lignan from Arctium lappa L., through inhibition on iNOS pathway. J. Ethnopharmacol. 122, 457-462 (2009) https://doi.org/10.1016/j.jep.2009.01.038